Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis
- Status
- COMPLETED
- Phase
- N/A
A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Relapsed Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE3
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE2